Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss | Clinical Pharmacy and Pharmacology | JAMA – JAMA Network October 5, 2023
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2 – Science September 13, 2023
EMA statement on ongoing review of GLP-1 receptor agonists | European Medicines Agency – European Medicines Agency | July 11, 2023
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA – The Lancet June 26, 2023
Serotonin 2C Receptor Associated With Obesity and Maladaptive Behavior December 20, 2022December 20, 2022
Study Suggests We Have This STI to Thank For The Evolution of Grandmothers July 23, 2022July 23, 2022
The Closest Related Virus to SARS-CoV-2 Has Just Been Discovered, And It’s in Bats September 27, 2021September 27, 2021